Supplementary table I. Concomitant immunomodulating therapy

IQR, interquartile range; no, number; SD, standard deviation; In total, 103 patients used systemic immunomodulating therapy after starting dupilumab. Eighteen of these patients were using systemic immunomodulating therapy from start dupilumab till study cut-off point: ciclosporin (n=6), azathioprine (n=2), methotrexate (n=4), mycophenolic acid/mycophenolate mofetil (n=3), systemic corticosteroids (n=3). Two patients stopped for respectively 14 and 33 days with systemic corticosteroids treatment and then restarted with systemic corticosteroids which they were still using at the end of study. This table displays the 83 patients that discontinued systemic concomitant immunomodulating therapy during the study.